| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000029229 |
| Receipt No. | R000033368 |
| Scientific Title | Transanal and transperineal total prostatectomy with total mesorectal excision for lower rectal cancer and proctal cancer |
| Date of disclosure of the study information | 2017/09/22 |
| Last modified on | 2022/11/08 (Ver. 9) |
| Basic information | ||
| Public title | Transanal and transperineal total prostatectomy with total mesorectal excision for lower rectal cancer and proctal cancer | |
| Acronym | Transanal and transperineal total prostatectomy with total mesorectal excision | |
| Scientific Title | Transanal and transperineal total prostatectomy with total mesorectal excision for lower rectal cancer and proctal cancer | |
| Scientific Title:Acronym | Transanal and transperineal total prostatectomy with total mesorectal excision | |
| Region |
|
|
| Condition | ||
| Condition | Lower Rectal Cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We are going to perform transanal (TaTMEP) and transperienal (TpTMEP) total prostatectomy with total mesorectal excision for the lower rectal cancer which invades the only middle part of the seminal vesicles or the prostate to achieve the proper surgical field and further improvement in manipulation. We investigate the safety, the oncological usefulness and the urinary function in TaTMEP and TpTMEP. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Surgical bleeding, surgical time, circumferential resected margin of the surgical specimen, leakage at the anastomotic site between the bladder and the urethra, post-surgical urinary function regarding voiding and continence |
| Key secondary outcomes | Post-surgical complications including urinary tract infection, pelvic abscess, paresis of intestine, and leakage at the coloanal anastomotic site post sphincter preserving surgery, closure rate of covering ileostoma, 3-year local recurrence rate, 3-year overall survival rate, and 3-year disease-free survival. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Transanal and transperineal total prostatectomy with total mesorectal excision | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) The patients with the lower rectal cancer which invades the only middle part of the seminal vesicles or the prostate.
2) The patients who agreed the entry of this study of their own free will in writing by a principal or a substitute after they had comprehended it well by enough explanation. |
|||
| Key exclusion criteria | 1) The patients with the lower rectal cancer which had widespread invasion of the seminal vesicles, the prostate, the pelvic nerve, the urinary bladder, and the urethra are excluded.
2) The patients who underwent neoadjuvant CRT in particular more than 45 Gry are e excluded because of much risk of leakage of the anastomotic site between the urinary bladder and the urethra. 3) When the proper surgical field or further improvement in manipulation cannot be obtained during TaTMEP or TpTMEP, the approach method should be changed into other approaches such as laparoscopy or open laparotomy, or other surgical methods such as transanal or transperineal total pelvic exenteration. 4) The patients who are inappropriate as the subjects of this study by the corresponding doctor are excluded. |
|||
| Target sample size | 5 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Saku Central Hospital Advanced Care Center | ||||||
| Division name | Digestive Surgery | ||||||
| Zip code | 385-0051 | ||||||
| Address | 3400-28 Nakagomi, Saku, 385-0051 JAPAN | ||||||
| TEL | 0267-62-8181 | ||||||
| gorontadu1110@circus.ocn.ne.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Saku Central Hospital Advanced Care Center | ||||||
| Division name | Clinical Research Center | ||||||
| Zip code | 385-0051 | ||||||
| Address | 3400-28 Nakagomi, Saku, 385-0051 JAPAN | ||||||
| TEL | 0267-62-8181 | ||||||
| Homepage URL | |||||||
| ctroffice@sakuhp.or.jp | |||||||
| Sponsor | |
| Institute | Saku Central Hospital Advanced Care Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Saku Central Hospital Advanced Care Center |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Saku Central Hospital Group Research Ethics Committee |
| Address | 197 Usuda, Saku, 384-0301 JAPAN |
| Tel | 0267-82-3131 |
| irboffice@sakuhp.or.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 佐久総合病院 佐久医療センター |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033368 |